FAQ

Antiphospholipid antibodies measurement

Known as: Antiphospholipid Antibody Measurement, APLAB, Anti-Phospholipid Antibody Measurement 
The determination of the amount of antiphospholipid antibodies present in a sample.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2018
051019922018

Related topics

Related topics

4 relations
Antiphospholipid AntibodiesCDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Related mentions per year

Related mentions per year

1962-2018
1960198020002020
Antiphospholipid antibodies measurement
Antiphospholipid Antibodies
Clinical Data Interchange Standards Consortium Terminology
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the occasion of the 14th International… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2012
2012
International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies.
 
Is this relevant?
2012
2012
Update on the catastrophic antiphospholipid syndrome and the "CAPS Registry".
Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the catastrophic variant known as catastrophic… (More)
  • table 1
  • figure 1
Is this relevant?
2011
2011
'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.
Abstract: Current classification criteria for definite APS recommend the use of one or more of three positive standardized… (More)
  • table 1
Is this relevant?
2010
2010
Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry'.
Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the catastrophic variant, its potentially… (More)
Is this relevant?
2008
2008
Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.
OBJECTIVES The purpose of this study was to obtain data on the association of antiphospholipid antibodies with clinical… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
CONTEXT The presence of antiphospholipid antibodies (aPL) has been associated with vascular occlusive events. However, the role… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2002
2002
Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group.
Inter-laboratory variability of anti-beta2-glycoprotein I antibody measurements (IgG and IgM) was investigated in the frame of… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants…
Lupus anticoagulants (LAs) are antibodies that interfere with phospholipid dependent coagulation reactions in vitro. This… (More)
Is this relevant?
1992
1992
Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. The Antiphospholipid Antibodies in Stroke Study Group.
Antiphospholipid antibodies are a marker for an increased risk of thrombosis, including stroke and transient ischemic attacks… (More)
Is this relevant?